{"id":55033,"date":"2023-03-21T14:07:33","date_gmt":"2023-03-21T13:07:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/"},"modified":"2023-03-21T14:07:33","modified_gmt":"2023-03-21T13:07:33","slug":"mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/","title":{"rendered":"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise"},"content":{"rendered":"
\n

CANTON, Mich.–(BUSINESS WIRE)–#biotech<\/a>–MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher\u2019s additions as advisors expand MMS\u2019 therapeutic area expertise to support growth in different therapeutic areas.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are pleased to welcome Dr. Breitfeld and Dr. Zeiher to our Scientific Advisory Board,\u201d said Uma Sharma, Ph.D., CEO of MMS. \u201cAt MMS, we work with our sponsors to support the development of groundbreaking therapies and bring them to market. Both Bernie and Phil bring much experience in different therapeutic areas and advanced drug development to guide our sponsors and teams with their expertise for many upcoming challenges.\u201d\n<\/p>\n

\nDr. Breitfeld has nearly 20 years of experience in the pharmaceutical industry and has led development and project teams focusing on Phase 1, Proof of Concept, and Pivotal trials in oncology. He has pharmaceutical development experience in solid tumor and malignant hematology, including leading oncology development at small biotechs and midsized global pharma companies.\n<\/p>\n

\nPrior to MMS, Dr. Breitfeld developed and led the Oncology Center of Excellence at IQVIA, the matrix organization that drives the long-term business agenda for oncology at the organization.\n<\/p>\n

\n\u201cI\u2019m excited to draw from my years of oncology experience to help MMS provide solutions for Sponsors and patients,\u201d said Dr. Breitfeld. \u201cI\u2019m joining a well-respected team of advisors and looking forward to working with them at such an innovative organization.\u201d\n<\/p>\n

\nDr. Zeiher has led the development of products in critical care, pain, immunology and infectious diseases. He was involved in and oversaw the approval of over 15 products.\n<\/p>\n

\nOver the course of his 20 years in the industry, he has held leadership and executive responsibility positions at Astellas, Pfizer and Lilly, including board memberships, Chief Medical Officer and President of Development.\n<\/p>\n

\n\u201cMMS does great work bringing life-changing therapies to patients,\u201d said Dr. Zeiher. \u201cI\u2019m passionate about addressing patients\u2019 unmet needs, and I\u2019m excited to work for an organization where I can use my years of experience to fulfill that goal.\u201d\n<\/p>\n

\nBoth join a team of industry-leading advisors at MMS. Learn more here.<\/a>\n<\/p>\n

\nAbout MMS<\/a><\/b>\n<\/p>\n

\nMMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAvery Zimmerman
\n
media@mmsholdings.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CANTON, Mich.–(BUSINESS WIRE)–#biotech–MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher\u2019s additions as advisors expand MMS\u2019 therapeutic area expertise to support growth in different therapeutic areas. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55033","6":"format-standard","7":"category-industry"},"yoast_head":"\nMMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CANTON, Mich.–(BUSINESS WIRE)–#biotech–MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher\u2019s additions as advisors expand MMS\u2019 therapeutic area expertise to support growth in different therapeutic areas. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T13:07:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230321005218\/en\/742567\/21\/MMS_logo_wTagline_white_background_8_24_17.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise\",\"datePublished\":\"2023-03-21T13:07:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/\"},\"wordCount\":454,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005218\\\/en\\\/742567\\\/21\\\/MMS_logo_wTagline_white_background_8_24_17.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/\",\"name\":\"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005218\\\/en\\\/742567\\\/21\\\/MMS_logo_wTagline_white_background_8_24_17.jpg\",\"datePublished\":\"2023-03-21T13:07:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005218\\\/en\\\/742567\\\/21\\\/MMS_logo_wTagline_white_background_8_24_17.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005218\\\/en\\\/742567\\\/21\\\/MMS_logo_wTagline_white_background_8_24_17.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/","og_locale":"en_US","og_type":"article","og_title":"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise - Pharma Trend","og_description":"CANTON, Mich.–(BUSINESS WIRE)–#biotech–MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher\u2019s additions as advisors expand MMS\u2019 therapeutic area expertise to support growth in different therapeutic areas. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-21T13:07:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230321005218\/en\/742567\/21\/MMS_logo_wTagline_white_background_8_24_17.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise","datePublished":"2023-03-21T13:07:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/"},"wordCount":454,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230321005218\/en\/742567\/21\/MMS_logo_wTagline_white_background_8_24_17.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/","url":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/","name":"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230321005218\/en\/742567\/21\/MMS_logo_wTagline_white_background_8_24_17.jpg","datePublished":"2023-03-21T13:07:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230321005218\/en\/742567\/21\/MMS_logo_wTagline_white_background_8_24_17.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230321005218\/en\/742567\/21\/MMS_logo_wTagline_white_background_8_24_17.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mms-scientific-advisory-boards-new-members-expand-cros-therapeutic-expertise\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MMS Scientific Advisory Board\u2019s New Members Expand CRO\u2019s Therapeutic Expertise"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55033"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55033\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}